Nestle S A : - Reinforcing microbiome research for the next generation of health-promoting products
November 25, 2019 at 08:04 am EST
Share
To further increase the understanding of the microbiome's impact on human health and to accelerate the development of innovative nutritional solutions promoting health and wellbeing, Nestle has entered into a partnership with the University of California San Diego Center for Microbiome Innovation (CMI).
The partnership builds on the CMI's world-class microbiome expertise which complements Nestle's research capabilities on the connection between nutrition and the gut microbiome.
The microbiome is the vast community of microbes such as bacteria, fungi, and viruses that live on and inside the body. An important part of the microbiome is located in the gut where it is essential to digesting the food we eat, the immune system, and other aspects of health.
Over many years, Nestle has studied the gut microbiome and its evolving composition throughout different life stages, from birth to aging, in humans and pets. This research has been translated into products that help maintain healthy digestion and wellbeing for different populations. The current portfolio includes products containing probiotics, prebiotics, and synbiotics to improve digestion.
Nestle has also researched Human Milk Oligosaccharides (HMOs), a major component of breastmilk that has been shown to influence early life microbiome establishment and development of the immune system. The findings were leveraged to launch new infant formulas that include HMOs.
More recently, Nestle Purina launched Calming Care, an innovative probiotic-based nutritional supplement tailored for the management of anxious behavior in dogs.
'The microbiome is an important research area for us,' said Isabelle Bureau-Franz, Head of Nestle Research. 'In addition to the continuous development of our innovative products, we are investing in long-term research enabling us to provide the next generation of personalized nutritional solutions adapted to the individual's microbiome.'
The partnership with CMI opens new opportunities for accelerating microbiome discoveries through joint research programs and access to scientific and technological capabilities complementing those already existing within the Nestle research and development network. The partnership will also provide the opportunity to work with young talents in the frame of CMI's PhD student and postdoctoral programs.
Nestlé S.A. is the world's leading agri-food group. Net sales break down by category of products as follows:
- powdered and liquid beverages (26.7%): soluble coffees (Nescafé and Starbucks brands), coffee in capsules (Nespresso), chocolate drinks (Nesquik, Milo, etc.), tea drinks (Nestea), etc.;
- pet food (20.3%): brands such as Purina, Friskies, Felix, etc.;
- pharmaceutical, nutrition and well-being products (16.4%): nutritional supplements (Resource, Boost, Nutren, Optifast, Peptamen brands, etc.), infant and maternal nutrition products (NAN, illuma, Cerelac, Nido, Gerber), ketogenic beverages (BrainXpert), (Nesquick, Fitness, Cheerios, Lion, etc.), etc.;
- ready meals and seasoning products (12.5%): frozen and chilled dishes (Lean Cuisine, Hot Pockets and Stouffer's brands), soups (Maggi), etc.;
- dairy products and ice cream (11.8%): powdered milk, sweetened condensed milk, yoghurt and cream desserts, ice cream (Nido, Nesvita, Carnation, La Laitière, Coffee Mate, Nestlé Ice Cream, Dreyers, Häagen-Dazs, Extrême brands, etc.);
- chocolates, sweets and biscuits (8.7%): Kit Kat, Smarties, Cailler, Terrafertil, etc. brands;
- bottled waters (3.6%): Nestlé Pure Life, Vittel, Perrier, S. Pellegrino, etc. brands.
Net sales are distributed geographically as follows: Switzerland (1.2%), France (3.8%), the United Kingdom (3.8%), Germany (2.4%), Europe (12.8%), the United States and Canada (35%), China (5.9%), Asia and Oceania (21.4%) and Latin America (13.7%).
NESTLÉ S.A. 
